Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia

Platelets

Volumn 20, Issue 7, 2009, Pages 525-527

  Naithani, Rahul ^a   Kumar, Rajat ^a   Mahapatra, M ^a   Tyagi, Seema ^a   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anti D; Bleeding; ITP

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; RHESUS D ANTIBODY;

ADULT; ARTHRALGIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD DISEASE; BLOOD GROUP ABO SYSTEM; CHILL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FLUSHING; HEMOGLOBIN BLOOD LEVEL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; JAUNDICE; MALE; MYALGIA; PAIN; POLYCHROMASIA; PRIORITY JOURNAL; SEX; SHEROCYTOSIS; SIDE EFFECT; THROMBOCYTE COUNT; TIME;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RHO(D) IMMUNE GLOBULIN; YOUNG ADULT;

EID: 70350494532     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537100903144617     Document Type: Article

References (17)

1. Arnold DM, Kelton JG. Current options for the treatment of idiopathic thrombocytopenic purpura. Semin Hematol 2007;44(suppl 5):s12-s23.
2. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
3. Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM. Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect. Blood 1991;77:1884-1893.
4. Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood 2007;109:1401-1407.
5. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009;113(11): 2386-2393.
6. Scaradavou A, Woo B, Woloski BMR, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients. Blood 1997;89:2689-2700.
7. Aledort LM, Salama A, Kovaleva L, et al. Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac-) in chronic immune thrombocytopenic purpura. Hematology 2007;12:289-295.
8. Newman GC, Novoa MV, Fodero EM, et al. A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura. Br J Hematol 2001;112:1076-1078.
9. Rodeghiero F, Schiavotto C, Castaman G, Vespignani M, Ruggeri M, Dini E. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with highdose immunoglobulins and anti-D immunoglobulins. Haematologica 1992;77:248-252.
10. Cooper N, Woloski BM, Fodero EM, Novoa M, Leber M, Beer JH, Bussel JB. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Blood 2002;99:1922-1927.
11. Schwartz J, Spitalnik S, Grima KM. Severe hemolysis following administration of Rho(D) immune globulin in an ITP patient associated with anti-C. Blood 2006;107:2585.
12. Sandler SG, Mallory D, Trimble J, Nance ST. Intravenous anti-D treatment for immune thrombocytopenic purpura. Blood 1998;91:2624-2625.
13. Kjaersgaard M, Aslam R, Kim M, Speck ER, Freedman J, Stewart DIH, Wiersma EJ, Semple JW. Epitope specificity and isotype of monoclonal anti-D antibodies dictate their ability to inhibit phagocytosis of opsonized platelets. Blood 2007;110:1359-1361.
14. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120(4):574-596.
15. Ramadan KM, El-Agnaf M. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura. Clin Lab Haematol 2005;27(4):267-269.
16. Kayyali HR, Abdelmoity AT, Morriss MC, Graf WD. Cerebral venous thrombosis after immune thrombocytopenic purpura and anti-D immune globulin therapy. J Child Neurol 2008;23(3):325-330.
17. Berger-Achituv S, Ellis MH, Curtis BR, Wolach B. Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent. Am J Hematol 2008;83(8):676-678.